First Home Sperm Test device launched in India

First time in India, home sperm test device to count moving sperm has been approved by FDA. A Los Angeles based company Medical Electronic Systems (MES) which has specialization in rapid Automated Semen Analysis and announced the launch of YO® Home Sperm Test in India. YO® offers video-based smartphone platform and measure Motile Sperm Concentration (the number of moving sperm) which is a critical factor in determining male fertility. YO® is very innovative and first of its kind device in India.

YO® offers accuracy rate of 97% and a user can view and measure the number of motile (moving) sperm in their samples on their phone. This device offers the comfort of home and makes male fertility testing an easy process.

MES developed this kit to address the problem of delayed male testing and to eliminate the stressful public nature of male sperm analysis. YO® provides an accurate assessment of moving sperm concentration (MSC).

YO® provides full proof evidence with video to a user to show it to the doctor their problem and converts critical moving sperm testing easier at home. Male factor infertility test becomes very common and this device YO® will become a game changer in India and Worldwide.

Users can buy YO® Home Sperm Test kit from their website and on Amazon India for INR 1990. Users can analyze their sperm count easily and can experience/ analyze the change with making a change in their lifestyle.

 

Related Posts

‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

Domestic Medical Device Leaders cry foul against move to do away with Policy Restrictions New Delhi:  The union government mandarins seem to be at it again, diametrically opposed to Prime…

Indigenous Robotic Surgery is Mantra for Accessible Cancer Care in India

Best in Class ‘Made in India’ Surgical Robot is proving Best Bet New Delhi: ‘Made in India’ best in class surgical robot SSiMantra is proving godsend for cancer patients in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward